Related Experiment Video

Updated: Mar 23, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

22.4K

Hyperuricemia and Cardiovascular Disease in Patients with Hypertension

Andres Acevedo, Julian Benavides, Mohsin Chowdhury

    Connecticut Medicine
    |March 31, 2016
    PubMed

    Insights

    High serum uric acid (hyperuricemia) affects 28.8% of hypertensive patients. This condition is linked to cardiovascular disease risk factors like male gender, age, BMI, and abnormal lipid levels.

    Area of Science:

    • Cardiology
    • Metabolic Syndrome Research
    • Clinical Hypertension

    Background:

    • The role of serum uric acid in cardiovascular events remains largely uncharacterized.
    • This study investigates the prevalence of hyperuricemia and its association with cardiovascular risk factors in hypertensive patients.

    Purpose of the Study:

    • To determine the prevalence of hyperuricemia in a hypertensive patient population.
    • To explore the relationship between serum uric acid levels and various cardiovascular risk factors.

    Main Methods:

    • Cross-sectional study design.
    • Inclusion of 444 hypertensive patients from a university hospital clinic in Bogotá, Colombia.
    • Bivariate and multivariate logistic regression analyses to assess associations.

    Main Results:

    • The prevalence of hyperuricemia was found to be 28.8%.
    • Significant associations were observed between hyperuricemia and male gender, increasing age, higher body mass index (BMI), elevated triglyceride levels, and lower high-density lipoprotein (HDL) cholesterol levels.

    Conclusions:

    • Hyperuricemia is highly prevalent in patients with hypertension.
    • Serum uric acid levels are significantly associated with key metabolic syndrome parameters.
    • Hyperuricemia warrants recognition and monitoring as a cardiovascular disease risk factor.
    Abstract

    More Related Videos

    Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug05:57

    Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

    Published on: May 17, 2024

    1.3K
    Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

    Assessment of Vascular Function in Patients With Chronic Kidney Disease

    Published on: June 16, 2014

    16.9K

    Related Concept Videos

    Hypertension and Regulation of Blood Pressure01:18

    Hypertension and Regulation of Blood Pressure

    Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
    4.7K
    Antihypertensive Drugs: Action of Diuretics01:16

    Antihypertensive Drugs: Action of Diuretics

    Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
    2.8K
    Hypertension II: Pathophysiology01:29

    Hypertension II: Pathophysiology

    Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
    1.4K
    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...
    733
    Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

    Hypertension III: Clinical Manifestations and Diagnostic Studies

    Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
    710
    Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

    Cardiovascular Drugs: Classification based on Therapeutic Indications

    Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
    4.5K